TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 5 | -1 | 7 | -4 | -42 | -90 | -90 | -37 |
S | %wins | 40 | 60 | 40 | 80 | 100 | 100 | 70 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/15 16:09 | 4/1/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -85 | 19.13 | 33 | -4 | -76 | 1 | D | 60 | 79 | -9 | 9 | -34 | -28 | -18 | 3 | -3 | -86 | -93 | -95 | ||
3/3/15 21:13 | 3/2/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -144 | 18.48 | 6 | -8 | -84 | 1 | D | 67 | 61 | 51 | 5 | 21 | 16 | 6 | 4 | 32 | 1 | -87 | -93 | ||
2/3/15 18:21 | 2/2/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -127 | 16.35 | 4 | -8 | -84 | 1 | D | 99 | 33 | 57 | -9 | -8 | 3 | -3 | -2 | -2 | 21 | -80 | -88 | ||
1/5/15 20:44 | 1/2/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -155 | 19.88 | 6 | -8 | -84 | 1 | D | 24 | 96 | 72 | 22 | 11 | -2 | -12 | -4 | -16 | -8 | -89 | |||
12/2/14 19:01 | 12/1/14 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Takeya Ryan K | CA | O | VP,Manuf | S.d | -93 | 12.01 | 1 | -8 | -93 | 1 | D | 51 | 5 | 22 | 3 | 2 | -2 | 3 | 11 | 59 | 60 | -86 | -90 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |